Terug
21
38
48
35
35
Dagbereik
€ 41,87
€ 43,48
52-Weeksbereik
€ 32,38
€ 49,62
Volume
1.832.265
50D / 200D Gem.
€ 43,04
/
€ 41,57
Vorige Slotkoers
€ 41,57
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (627 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 14,7 | 0,3 |
| P/B | 5,3 | 3,0 |
| ROE % | 35,5 | 3,7 |
| Net Margin % | 33,7 | 3,8 |
| Rev Growth 5Y % | 12,8 | 10,0 |
| D/E | 0,1 | 0,2 |
Koersdoel Analisten
Hold
€ 44,11
+3.1%
Low: € 30,00
High: € 54,00
Forward K/W
14,51
Forward WPA
€ 2,95
WPA Groei (sch.)
+0,0%
Omzet Sch.
2,32B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2031 |
€ 5,48
€ 4,92 – € 5,98
|
3,19B | 6 |
| FY2030 |
€ 5,57
€ 5,01 – € 6,09
|
3,42B | 5 |
| FY2029 |
€ 4,77
€ 2,26 – € 7,45
|
3,26B | 12 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-10 | € 0,83 | € 0,94 | +13,3% |
| 2025-11-04 | € 0,69 | € 0,78 | +13,9% |
| 2025-07-28 | € 0,65 | € 0,75 | +15,4% |
| 2025-05-13 | € 0,36 | € 0,62 | +73,1% |
| 2025-02-11 | € 0,51 | € 0,55 | +7,8% |
| 2024-10-29 | € 0,35 | € 0,40 | +14,3% |
| 2024-08-06 | € 0,30 | € 0,77 | +156,7% |
| 2024-04-30 | € 0,28 | € 0,17 | -39,3% |
Dividend History
Yield
0,00%
Payout Ratio
0,00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Belangrijkste Punten
Revenue grew 12,76% annually over 5 years — strong growth
Earnings grew 50,13% over the past year
ROE of 35,53% indicates high profitability
Net margin of 33,73% shows strong profitability
Debt/Equity of 0,08 — conservative balance sheet
Generating 844,34M in free cash flow
Groei
Revenue Growth (5Y)
12,76%
Revenue (1Y)6,98%
Earnings (1Y)50,13%
FCF Growth (3Y)122,63%
Kwaliteit
Return on Equity
35,53%
ROIC28,02%
Net Margin33,73%
Op. Margin37,59%
Veiligheid
Debt / Equity
0,08
Current Ratio3,56
Interest Coverage0,00
Waardering
P/E Ratio
14,66
Forward P/E14,05
P/B Ratio5,31
EV/EBITDA12,80
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 6,98% | Revenue Growth (3Y) | 12,59% |
| Earnings Growth (1Y) | 50,13% | Earnings Growth (3Y) | 94,08% |
| Revenue Growth (5Y) | 12,76% | Earnings Growth (5Y) | 35,66% |
| Profitability | |||
| Revenue (TTM) | 2,32B | Net Income (TTM) | 782,57M |
| ROE | 35,53% | ROA | 27,51% |
| Gross Margin | 96,39% | Operating Margin | 37,59% |
| Net Margin | 33,73% | Free Cash Flow (TTM) | 844,34M |
| ROIC | 28,02% | FCF Growth (3Y) | 122,63% |
| Safety | |||
| Debt / Equity | 0,08 | Current Ratio | 3,56 |
| Interest Coverage | 0,00 | ||
| Dividends | |||
| Dividend Yield | 0,00% | Payout Ratio | 0,00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 14,66 | Forward P/E | 14,05 |
| P/B Ratio | 5,31 | P/S Ratio | 4,94 |
| PEG Ratio | 0,25 | Forward PEG | N/A |
| EV/EBITDA | 12,80 | Fwd EV/EBITDA | 8,08 |
| Forward P/S | 4,94 | Fwd Earnings Yield | 7,12% |
| FCF Yield | 7,36% | ||
| Market Cap | 11,47B | Enterprise Value | 11,16B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,32B | 2,17B | 1,83B | 1,61B | 1,43B |
| Net Income | 782,57M | 521,27M | 207,77M | 182,28M | 231,06M |
| EPS (Diluted) | 2,78 | 1,76 | 0,65 | 0,56 | 0,72 |
| Gross Profit | 2,24B | 2,09B | 1,76B | 1,55B | 1,38B |
| Operating Income | 872,19M | 604,62M | 170,89M | 201,48M | 286,67M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2,84B | 2,95B | 2,94B | 3,07B | 2,62B |
| Total Liabilities | 683,10M | 703,49M | 678,45M | 583,06M | 405,62M |
| Shareholders' Equity | 2,16B | 2,24B | 2,26B | 2,49B | 2,21B |
| Total Debt | 173,04M | 190,82M | 189,94M | 190,17M | 51,27M |
| Cash & Equivalents | 482,49M | 217,37M | 262,99M | 501,20M | 647,17M |
| Current Assets | 1,44B | 1,47B | 1,32B | 1,62B | 1,83B |
| Current Liabilities | 405,64M | 403,77M | 394,28M | 324,36M | 337,59M |
Strategiescores
This stock passed the criteria for 5 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Cash Flow Compounder
#964 of 1052
Custom
Capital Light Compounder
#124 of 218
Growth + Value
Growth at a Reasonable Price (Peter Lynch)
#191 of 332
Custom
Balanced Risk
#120 of 151
Custom
Lower Risk
#113 of 140
Recente Activiteit
Ingestapt
Cash Flow Compounder
Mar 24, 2026
Ingestapt
Capital Light Compounder
Mar 24, 2026
Ingestapt
Growth at a Reasonable Price (Peter Lynch)
Mar 24, 2026
Ingestapt
Balanced Risk
Mar 24, 2026
Ingestapt
Lower Risk
Mar 24, 2026